CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16
CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16
批准号:
6497666
负责人:
Mayumi Nakagawa
金额:
$8.59万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-02-01 至 2004-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Description) As a student in an M.D.-Ph.D.
program at Albert Einstein College of Medicine, Dr. Nakagawa studied the
structure function relationships of murine Major Histocompatibility Complex
in terms of its immunological and physiological properties. After
completing a residency program in laboratory medicine at the University of
California at San Francisco, where she still is, she began a research
project studying cell-mediated immunity to Human Papilloma Virus type 16
(HPV 16) which is a causative agent of cervical dysplasia and cancer. Data
collected thus far, using a T cell proliferative assay as well as a
cytotoxic lymphocyte assay, support her working hypothesis that
cell-mediated immunity to HPV is instrumental in its elimination and thus is
protected against the development of associated diseases. The experiments
proposed in this application are nested with an ongoing longitudinal study
in which HPV 16 infected women who have not developed high grade
intraepithelial lesions are tested for cytotoxic T lymphocyte responses to
HPV 16 oncogenic proteins, E6 and E7. The specific aims of this project are
to characterize the lymphocyte subset(s) responsible for anti-HPV activity,
to eliminate background activity, to explore alternative methods of in vitro
stimulation, and to develop a protocol to perform cytotoxic T lymphocyte
assay using T cell lines instead of bulk cultures. The last aim will give
us a tool to identify immunodominant epitopes of HPV 16 in the future. The
long-term goal of this project is to develop effective vaccines and
immunotherapy for prevention and treatment of cervical cancer.
Dr. Nakagawa's long-term career goal is to continue research in HPV
immunology as an independent investigator. She envisions this will be best
accomplished by becoming a faculty member at an academic medical center
where she will also have clinical responsibilities as a laboratory medicine
physician. The University of California at San Francisco, which is a major
academic medical institution with many distinguished scientists, offers an
excellent environment to develop skills and further her expertise in the
field to accomplish her goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal
-
批准号:10306208
-
项目类别:
-
资助金额:$72.73万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses
-
批准号:8077943
-
项目类别:
-
资助金额:$69.94万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses
-
批准号:8657864
-
项目类别:
-
资助金额:$47.68万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal
-
批准号:10661537
-
项目类别:
-
资助金额:$72.73万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses
-
批准号:8249895
-
项目类别:
-
资助金额:$63.92万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses
-
批准号:7986855
-
项目类别:
-
资助金额:$77.48万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal
-
批准号:10415203
-
项目类别:
-
资助金额:$71.27万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses
-
批准号:9036591
-
项目类别:
-
资助金额:$54.5万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
Understanding and Enhancing T-Cell Responses to high Risk Human Papillomaviruses
-
批准号:8458616
-
项目类别:
-
资助金额:$46.46万
-
财政年份:2010
-
负责人:Mayumi Nakagawa
-
依托单位:
CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16
-
批准号:6150274
-
项目类别:
-
资助金额:$8.59万
-
财政年份:1998
-
负责人:Mayumi Nakagawa
-
依托单位:
CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16
-
批准号:2440237
-
项目类别:
-
资助金额:$8.59万
-
财政年份:1998
-
负责人:Mayumi Nakagawa
-
依托单位:
CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16
-
批准号:2871981
-
项目类别:
-
资助金额:$8.59万
-
财政年份:1998
-
负责人:Mayumi Nakagawa
-
依托单位:
CYTOTOXIC T LYMPHOCYTE RESPONSE TO HPV 16
-
批准号:6350250
-
项目类别:
-
资助金额:$8.59万
-
财政年份:1998
-
负责人:Mayumi Nakagawa
-
依托单位:
海外基金